Literature DB >> 31858269

Oligosaccharyltransferase PglB of Campylobacter jejuni is a glycoprotein.

Habib Bokhari1, Arooma Maryam2, Ramla Shahid2, Abdul Rauf Siddiqi2.   

Abstract

Campylobacter jejuni is the one of the leading cause of bacterial food borne gastroenteritis. PglB, a glycosyltransferase, plays a crucial role of mediating glycosylation of numerous periplasmic proteins. It catalyzes N-glycosylation at the sequon D/E-X1-N-X2-S/T in its substrate proteins. Here we report that the PglB itself is a glycoprotein which self-glycosylates at N534 site in its DYNQS sequon by its own catalytic WWDYG motif. Site-directed mutagenesis, lectin Immunoblot, and mobility shift assays confirmed that the DYNQS is an N-glycosylation motif. PglB's N-glycosylation motif is structurally and functionally similar to its widely studied glycosylation substrate, the OMPH1. Its DYNQS motif forms a solvent-exposed crest. This motif is close to a cluster of polar and hydrophilic residues, which form a loop flanked by two α helices. This arrangement extremely apposite for auto-glycosylation at N534. This self-glycosylation ability of PglB could mediate C. jejuni's ability to colonize the intestinal epithelium. Further this capability may also bear significance for the development of novel conjugated vaccines and diagnostic tests.

Entities:  

Keywords:  C. jejuni; Glycoproteins; Glycosylation; Oligosaccharyltransferase; PglB; Vaccine

Mesh:

Substances:

Year:  2019        PMID: 31858269     DOI: 10.1007/s11274-019-2784-9

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  52 in total

Review 1.  Glycosylation and biogenesis of a family of serine-rich bacterial adhesins.

Authors:  Meixian Zhou; Hui Wu
Journal:  Microbiology (Reading)       Date:  2009-02       Impact factor: 2.777

2.  Comparative protein modelling by satisfaction of spatial restraints.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

3.  Production of initial-stage eukaryotic N-glycan and its protein glycosylation in Escherichia coli.

Authors:  Akkaraphol Srichaisupakit; Takao Ohashi; Ryo Misaki; Kazuhito Fujiyama
Journal:  J Biosci Bioeng       Date:  2014-10-16       Impact factor: 2.894

4.  From peptide to protein: comparative analysis of the substrate specificity of N-linked glycosylation in C. jejuni.

Authors:  Mark M Chen; Kerney Jebrell Glover; Barbara Imperiali
Journal:  Biochemistry       Date:  2007-04-17       Impact factor: 3.162

5.  N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli.

Authors:  Michael Wacker; Dennis Linton; Paul G Hitchen; Mihai Nita-Lazar; Stuart M Haslam; Simon J North; Maria Panico; Howard R Morris; Anne Dell; Brendan W Wren; Markus Aebi
Journal:  Science       Date:  2002-11-29       Impact factor: 47.728

6.  Chemoenzymatic synthesis of glycopeptides with PglB, a bacterial oligosaccharyl transferase from Campylobacter jejuni.

Authors:  Kerney Jebrell Glover; Eranthie Weerapana; Shin Numao; Barbara Imperiali
Journal:  Chem Biol       Date:  2005-12

7.  Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding.

Authors:  Andrei-J Petrescu; Adina-L Milac; Stefana M Petrescu; Raymond A Dwek; Mark R Wormald
Journal:  Glycobiology       Date:  2003-09-26       Impact factor: 4.313

Review 8.  Roles of N-linked glycans in the endoplasmic reticulum.

Authors:  Ari Helenius; Markus Aebi
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

9.  Cost-effectiveness of a potential vaccine candidate for Haemophilus influenzae serotype 'a'.

Authors:  Affan Shoukat; Robert Van Exan; Seyed M Moghadas
Journal:  Vaccine       Date:  2018-02-16       Impact factor: 3.641

10.  Functional analysis of the Campylobacter jejuni N-linked protein glycosylation pathway.

Authors:  Dennis Linton; Nick Dorrell; Paul G Hitchen; Saba Amber; Andrey V Karlyshev; Howard R Morris; Anne Dell; Miguel A Valvano; Markus Aebi; Brendan W Wren
Journal:  Mol Microbiol       Date:  2005-03       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.